Immune cell response to strenuous resistive breathing: comparison with whole body exercise and the effects of antioxidants

por Asimakos, Andreas, Toumpanakis, Dimitrios, Karatza, Maria-Helena, Vasileiou, Spyridoula, Katsaounou, Paraskevi, Mastora, Zafeiria, Vassilakopoulos, Theodoros
Publicado 2018

Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections

por Vasileiou, Spyridoula, Turney, Anne M., Kuvalekar, Manik, Mukhi, Shivani S., Watanabe, Ayumi, Lulla, Premal, Ramos, Carlos A., Naik, Swati, Vera, Juan F., Tzannou, Ifigeneia, Leen, Ann M.
Publicado 2020

Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination

por Vasileiou, Spyridoula, Kuvalekar, Manik, Velazquez, Yovana, Watanabe, Ayumi, Narula, Mansi, Workineh, Aster G., French-Kim, Matthew, Chavez, Alejandro Torres, Gilmore, Sarah, Rooney, Cliona M., Leen, Ann M.
Publicado 2022

Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19

por Vasileiou, Spyridoula, Kuvalekar, Manik, Workineh, Aster, Watanabe, Ayumi, Velazquez, Yovana, Lulla, Suhasini, Heslop, Helen E., Mooney, Kimberly, Grimes, Kevin, Carrum, George, Hill, LaQuisa, Lulla, Premal, Leen, Ann M.
Publicado 2021

37. Allogeneic, Off-the-Shelf, SARS-CoV-2-specific T Cells Demonstrate Reactivity Against Emerging Variant Strains

por Vasileiou, Spyridoula, Kuvalekar, Manik, Workineh, Aster, Watanabe, Ayumi, Velazquez, Yovana, Lulla, Suhasini, Heslop, Helen Elisabeth, Mooney, Kimberly, Grimes, Kevin, Carrum, George, Hill, LaQuisa, Lulla, Premal, Leen, Ann Marie
Publicado 2021

Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19

por Vasileiou, Spyridoula, Kuvalekar, Manik, Workineh, Aster, Watanabe, Ayumi, Velazquez, Yovana, Lulla, Suhasini, Heslop, Helen E., Mooney, Kimberly, Grimes, Kevin, Carrum, George, Hill, LaQuisa C., Lulla, Premal, Leen, Ann M.
Publicado 2020

Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients

por Vasileiou, Spyridoula, Hill, LaQuisa, Kuvalekar, Manik, Workineh, Aster G., Watanabe, Ayumi, Velazquez, Yovana, Lulla, Suhasini, Mooney, Kimberly, Lapteva, Natalia, Grilley, Bambi J., Heslop, Helen E., Rooney, Cliona M., Brenner, Malcolm K., Eagar, Todd N., Carrum, George, Grimes, Kevin A., Leen, Ann M., Lulla, Premal
Publicado 2022

Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer

por Hoyos, Valentina, Vasileiou, Spyridoula, Kuvalekar, Manik, Watanabe, Ayumi, Tzannou, Ifigeneia, Velazquez, Yovana, French-Kim, Matthew, Leung, Wingchi, Lulla, Suhasini, Robertson, Catherine, Foreman, Claudette, Wang, Tao, Bulsara, Shaun, Lapteva, Natalia, Grilley, Bambi, Ellis, Matthew, Osborne, Charles Kent, Coscio, Angela, Nangia, Julie, Heslop, Helen E., Rooney, Cliona M., Vera, Juan F., Lulla, Premal, Rimawi, Mothaffar, Leen, Ann M.
Publicado 2022